City
Epaper

Even mild fatty liver disease may up death risk: Study

By IANS | Published: October 15, 2020 1:24 PM

New York, Oct 15 In a major study, researchers have found an increased risk of death in patients with ...

Open in App

New York, Oct 15 In a major study, researchers have found an increased risk of death in patients with non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis or cirrhosis.

The study, published in the journal Gut, show that mortality increases with disease severity, but even mild fatty liver disease is linked to higher mortality.

Small clinical studies have demonstrated that among patients with NAFLD, advanced liver fibrosis is the most important histological predictor of mortality, but until now, population-level data have been missing from cohorts with liver histology.

"This is the first nationwide cohort study with detailed liver histology data to confirm that NAFLD contributes to an increased risk of all-cause mortality," said study first author Tracey G Simon from the Massachusetts General Hospital in the US.

Non-alcoholic fatty liver disease is often caused by obesity and affects nearly 25 per cent of the US and European adults. It represents the most common cause of chronic liver disease in Western countries.

For the current results, the research team matched 10,568 individuals with biopsy-confirmed NAFLD to general population controls through Sweden's comprehensive, nationwide registers.

They found that all stages of NAFLD were associated with excess mortality risk, even early stages of disease.

This risk was driven primarily by deaths from extra-hepatic cancer and cirrhosis, while the risks of cardiovascular mortality or hepatocellular carcinoma (HCC) mortality were relatively modest.

Patients with NAFLD had a 93 per cent increased risk of all-cause mortality, but the numbers varied with disease severity.

The risk increased progressively from the mildest form of NAFLD (simple steatosis), to non-fibrotic steatohepatitis (NASH), to non-cirrhotic fibrosis and to severe NAFLD with liver cirrhosis.

These findings should be used to develop more targeted interventions designed to reduce mortality, in patients with NAFLD," Simon said.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: NafldTracey g simonMassachusetts General Hospital
Open in App

Related Stories

HealthPlant-based meal packages associated with lower BMI in children: Study

HealthPlant-based food packages linked to lower BMI in children: Research

HealthStudy finds gut microbiome changes associated with precancerous colon polyps

HealthStudy suggests TB vax may reduce risk of Alzheimer's

HealthGenes expressed in brain before birth can affect risk of childhood mental disease

Health Realted Stories

HealthMBBS student appears for NEET-2024 exam in place of younger brother, both arrested

HealthResearchers find how eye ultrasounds help detecting brain shunt failure in children

HealthTN Health Dept launches counselling services as Class 12 board results announced

HealthAssam: Infant dies due to swine flu after relatives refuse treatment

HealthFLiRT Covid variants: No need for panic or extra caution, say experts